90 related articles for article (PubMed ID: 38101781)
41. What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality?
Tahir Huyut M; Huyut Z; İlkbahar F; Mertoğlu C
Int Immunopharmacol; 2022 Apr; 105():108542. PubMed ID: 35063753
[TBL] [Abstract][Full Text] [Related]
42. The prognostic significance of erythrocyte sedimentation rate in COVID-19.
Kaya T; Nalbant A; Kılıçcıoğlu GK; Çayır KT; Yaylacı S; Varım C
Rev Assoc Med Bras (1992); 2021 Sep; 67(9):1305-1310. PubMed ID: 34816925
[TBL] [Abstract][Full Text] [Related]
43. Neutrophils and Lymphocytes Can Help Distinguish Asymptomatic COVID-19 From Moderate COVID-19.
Gu X; Sha L; Zhang S; Shen D; Zhao W; Yi Y
Front Cell Infect Microbiol; 2021; 11():654272. PubMed ID: 34722325
[TBL] [Abstract][Full Text] [Related]
44. Role of NLR, PLR, ELR and CLR in differentiating COVID-19 patients with and without pneumonia.
Damar Çakırca T; Torun A; Çakırca G; Portakal RD
Int J Clin Pract; 2021 Nov; 75(11):e14781. PubMed ID: 34482573
[TBL] [Abstract][Full Text] [Related]
45. Role of platelet-to-lymphocyte count ratio (PLR), as a prognostic indicator in COVID-19: A systematic review and meta-analysis.
Sarkar S; Kannan S; Khanna P; Singh AK
J Med Virol; 2022 Jan; 94(1):211-221. PubMed ID: 34436785
[TBL] [Abstract][Full Text] [Related]
46. A systematic meta-analysis of immune signatures in patients with COVID-19.
Liu K; Yang T; Peng XF; Lv SM; Ye XL; Zhao TS; Li JC; Shao ZJ; Lu QB; Li JY; Liu W
Rev Med Virol; 2021 Jul; 31(4):e2195. PubMed ID: 34260780
[TBL] [Abstract][Full Text] [Related]
47. Targeting glucose metabolism for treatment of COVID-19.
Ardestani A; Azizi Z
Signal Transduct Target Ther; 2021 Mar; 6(1):112. PubMed ID: 33677470
[No Abstract] [Full Text] [Related]
48. Haematologic indices and disease activity index in primary Sjogren's syndrome.
Yıldız F; Gökmen O
Int J Clin Pract; 2021 Mar; 75(3):e13992. PubMed ID: 33405348
[TBL] [Abstract][Full Text] [Related]
49. How do routine laboratory tests change in coronavirus disease 2019?
Mertoglu C; Huyut MT; Arslan Y; Ceylan Y; Coban TA
Scand J Clin Lab Invest; 2021 Feb; 81(1):24-33. PubMed ID: 33342313
[TBL] [Abstract][Full Text] [Related]
50. COVID-19 diagnosis -A review of current methods.
Yüce M; Filiztekin E; Özkaya KG
Biosens Bioelectron; 2021 Jan; 172():112752. PubMed ID: 33126180
[TBL] [Abstract][Full Text] [Related]
51. Could ferritin level be an indicator of COVID-19 disease mortality?
Tural Onur S; Altın S; Sokucu SN; Fikri Bİ; Barça T; Bolat E; Toptaş M
J Med Virol; 2021 Mar; 93(3):1672-1677. PubMed ID: 32965712
[TBL] [Abstract][Full Text] [Related]
52. An inflammatory cytokine signature predicts COVID-19 severity and survival.
Del Valle DM; Kim-Schulze S; Huang HH; Beckmann ND; Nirenberg S; Wang B; Lavin Y; Swartz TH; Madduri D; Stock A; Marron TU; Xie H; Patel M; Tuballes K; Van Oekelen O; Rahman A; Kovatch P; Aberg JA; Schadt E; Jagannath S; Mazumdar M; Charney AW; Firpo-Betancourt A; Mendu DR; Jhang J; Reich D; Sigel K; Cordon-Cardo C; Feldmann M; Parekh S; Merad M; Gnjatic S
Nat Med; 2020 Oct; 26(10):1636-1643. PubMed ID: 32839624
[TBL] [Abstract][Full Text] [Related]
53. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
Pablos JL; Galindo M; Carmona L; Lledó A; Retuerto M; Blanco R; Gonzalez-Gay MA; Martinez-Lopez D; Castrejón I; Alvaro-Gracia JM; Fernández Fernández D; Mera-Varela A; Manrique-Arija S; Mena Vázquez N; Fernandez-Nebro A; ;
Ann Rheum Dis; 2020 Dec; 79(12):1544-1549. PubMed ID: 32796045
[TBL] [Abstract][Full Text] [Related]
54. Clinical characteristics, laboratory findings, radiographic signs and outcomes of 61,742 patients with confirmed COVID-19 infection: A systematic review and meta-analysis.
Pormohammad A; Ghorbani S; Baradaran B; Khatami A; J Turner R; Mansournia MA; Kyriacou DN; Idrovo JP; Bahr NC
Microb Pathog; 2020 Oct; 147():104390. PubMed ID: 32681968
[TBL] [Abstract][Full Text] [Related]
55. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients.
Zhang JJ; Cao YY; Tan G; Dong X; Wang BC; Lin J; Yan YQ; Liu GH; Akdis M; Akdis CA; Gao YD
Allergy; 2021 Feb; 76(2):533-550. PubMed ID: 32662525
[TBL] [Abstract][Full Text] [Related]
56. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
Wiersinga WJ; Rhodes A; Cheng AC; Peacock SJ; Prescott HC
JAMA; 2020 Aug; 324(8):782-793. PubMed ID: 32648899
[TBL] [Abstract][Full Text] [Related]
57. Platelet gene expression and function in patients with COVID-19.
Manne BK; Denorme F; Middleton EA; Portier I; Rowley JW; Stubben C; Petrey AC; Tolley ND; Guo L; Cody M; Weyrich AS; Yost CC; Rondina MT; Campbell RA
Blood; 2020 Sep; 136(11):1317-1329. PubMed ID: 32573711
[TBL] [Abstract][Full Text] [Related]
58. The inhibition of IL-2/IL-2R gives rise to CD8
Shi H; Wang W; Yin J; Ouyang Y; Pang L; Feng Y; Qiao L; Guo X; Shi H; Jin R; Chen D
Cell Death Dis; 2020 Jun; 11(6):429. PubMed ID: 32513989
[TBL] [Abstract][Full Text] [Related]
59. Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence.
Bohn MK; Lippi G; Horvath A; Sethi S; Koch D; Ferrari M; Wang CB; Mancini N; Steele S; Adeli K
Clin Chem Lab Med; 2020 Jun; 58(7):1037-1052. PubMed ID: 32459192
[TBL] [Abstract][Full Text] [Related]
60. Hemostatic laboratory derangements in COVID-19 with a focus on platelet count.
Amgalan A; Othman M
Platelets; 2020 Aug; 31(6):740-745. PubMed ID: 32456506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
